Emergent BioSolutions Inc. (EBS), headquartered in Gaithersburg, Maryland, is a leading life sciences firm dedicated to enhancing public health preparedness through its comprehensive suite of innovative solutions tailored for both civilian and military applications. The company excels in the development and manufacturing of vaccines, therapeutics, and diagnostics designed to combat significant public health threats, including emerging infectious diseases and bioterrorism. With a robust product portfolio and a firm commitment to health security, Emergent is strategically positioned to meet urgent global health needs while reinforcing organizational and governmental emergency response frameworks.